- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 303/14 - Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
Patent holdings for IPC class C07D 303/14
Total number of patents in this class: 86
10-year publication summary
5
|
6
|
7
|
6
|
4
|
4
|
7
|
3
|
1
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Del Mar Pharmaceuticals | 18 |
6 |
QBiotics Pty Ltd | 26 |
5 |
Del Mar Pharmaceuticals (BC) Ltd. | 19 |
4 |
China Petroleum & Chemical Corporation | 1804 |
3 |
Sumitomo Chemical Company, Limited | 9004 |
2 |
Kao Corporation | 4935 |
2 |
The Brigham and Women's Hospital, Inc. | 2146 |
2 |
Fundacion Tecnalia Research & Innovation | 209 |
2 |
JNC Corporation | 1535 |
2 |
JNC Petrochemical Corporation | 403 |
2 |
Profectus Biosciences, Inc. | 10 |
2 |
QBiotics Limited | 7 |
2 |
Research Institute of Petroleum Processing, Sinopec | 382 |
2 |
Washington University | 1555 |
2 |
Green Lizard Technologies Ltd | 13 |
2 |
BASF SE | 20548 |
1 |
Sandoz AG | 1409 |
1 |
Centre National de La Recherche Scientifique | 10163 |
1 |
Cheil Industries Inc. | 909 |
1 |
Corning Incorporated | 10145 |
1 |
Other owners | 41 |